Abstract
Diabetes is one of the common diseases in the world and its treatment faces
challenges. Insulin is the main therapeutic agent used in the treatment of diabetic
patients. However, it has several side effects and during the day, patients may need
several insulin injections, which is not pleasant for them. Therefore, a controlled and
prolonged release system is required to decrease the injection frequency, improve the
bioavailability of insulin, and enhance the compliance of patients. Nanoparticles (NPs)
based drug delivery systems (DDSs) have been considered for insulin delivery. NPs
can improve the permeability of insulin by opening the tight junctions between
intestinal epithelial cells and can protect insulin from the action of enzymes existing in
the gastrointestinal (GI) tract.
Related Journals
Current Dentistry
Current Psychopharmacology
Recent Advances in Anti-Infective Drug Discovery
Anti-Infective Agents
Adolescent Psychiatry
Current Aging Science
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current HIV Research
Current Neurovascular Research
Current Respiratory Medicine Reviews
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents